[99mTc]TRODAT-1: A novel technetium-99m complex as a dopamine transporter imaging agent

European Journal of Nuclear Medicine

Volumn 24, Issue 4, 1997, Pages 372-380

  Kung, Mei Ping ^a   Stevenson, D Andrew ^a   Plössl, Karl ^a   Meegalla, Sanath K ^a   Beckwith, Andrew ^a   Essman, William D ^a   Mu, Mu ^a   Lucki, Irwin ^a   Kung, Hank F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

6 OH dopamine; Autoradiography; Dopamine neuron; Single photon emission tomography; Striatum

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; [2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M; DOPAMINE TRANSPORTER; HALOPERIDOL; OXIDOPAMINE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; TROPANE DERIVATIVE; UNCLASSIFIED DRUG; CARRIER PROTEIN; DIAGNOSTIC AGENT; DOPAMINE; MEMBRANE PROTEIN; NERVE PROTEIN; TECHNETIUM COMPLEX; TECHNETIUM TC 99M TRODAT 1; TECHNETIUM TC 99M TRODAT-1;

ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BRAIN FUNCTION; BRAIN TISSUE; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DEGENERATIVE DISEASE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DOPAMINERGIC NERVE CELL; FEMALE; HOMOGENATE; INTRAVENOUS DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; ORGAN DISTRIBUTION; PARKINSON DISEASE; RAT; SUBSTANTIA NIGRA; ANIMAL; BRAIN; COMPARATIVE STUDY; DRUG EFFECT; METABOLISM; MOTOR ACTIVITY; SCINTISCANNING; SEX DIFFERENCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION;

ANIMALS; AUTORADIOGRAPHY; BRAIN; CARRIER PROTEINS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; ORGANOTECHNETIUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 0030612044     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050065     Document Type: Article

References (42)

1. Kuhar MJ, Sanchez-Roa PM, Wong DF, Dannals RF, Grigoriadis DE, Lew R, Milberger M. Dopamine transporter: biochemistry, pharmacology and imaging. Eur Neurol 1990; 30Suppl 1: 15-20.
2. Shimada S, Kitayama S, Lin C-L, Patel A, Nanthakumar E, Gregor P, Kuhar M, Uhl G. Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science 1991; 254: 576-277.
3. Kaufman MJ, Madras BK. Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's diseased striatum. Synapse 1991; 49: 43-49.
4. 3H]GBR-12935 in Alzheimer's disease. Eur Neurol 1990; 30: 181-185.
5. Fearnley JM, Less AJ. Aging and Parkinson's disease: substantia nigra regional selectivity. Brain 1991; 114: 2283-2301.
6. Volkow ND, Fowler JS, Gatley SJ, Logan J, Wang G-J, Ding Y-S, Dewey S. PET evaluation of the dopamine system of the human brain. J Nucl Med 1996; 37: 1242-1253.
7. 11C]-WIN 35428 reveals marked declines in mild Parkinson's disease. Ann Neurol 1993; 34: 423-431.
8. Laihinen AO, Rinne JO, Nägren K et al. PET studies on brain monoamine transporters with carbon-11-β-CIT in Parkinson's disease. J Nucl Med 1995; 36: 1263-1267.
9. 11C]nomifensine and positron emission tomography. Acta Neurol Scand 1987; 76: 283.
10. 123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease. Ann Neurol 1995; 38: 589-598.
11. Innis RB, Seibyl JP, Scanley BE et al. Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson's disease. Proc Natl Acad Sci USA 1993; 90: 11965-11969.
12. Shaya EK, Scheffel U, Dannals RF, Ricaurte GA, Carroll FI, Wagner HN Jr, Kuhar MJ, Wong DF. In vivo imaging of dopamine reuptake sites in the primate brain using single photon emission computed tomography (SPECT) and iodine-123 labeled RTI-55. Synapse 1992; 10: 169-172.
13. Kung M-P, Essman WD, Frederick D, Meegalla S, Goodman M, Mu M, Lucki I, Kung HF. IPT: a novel iodinated ligand for the CNS dopamine transporter. Synapse 1995; 20: 316-324.
14. Malison RT, Vessotskie JM, Kung M-P, McElgin W, Romaniello G, Kim H-J, Goodman MM, Kung HF. Striatal dopamine transporter imaging in nonhuman primates with iodine-123-IPT SPECT. J Nucl Med 1995; 36: 2290-2297.
15. Mozley PD, Stubbs JB, Kim H-J, McElgin W, Kung M-P, Meegalla S, Kung HF. Dosimetry of an iodine-123-labeled tropane to image dopamine transporters. J Nucl Med 1996; 37: 151-159.
16. Neumeyer JL, Wang S, Gao Y, Milius RA, Kula NS, Campbell A, Baldessarini RJ, Zea-Ponce Y, Baldwin RM, Innis RB. N-ω-Fluoroalkyl analogs of (1R)-2β-carbomethoxy-3β-(4-iodophenyl)-tropane (β-CIT): radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transporters. J Med Chem 1994; 37: 1558-1561
17. Kuikka JT, Akerman K, Bergstrom KA, Karhu J, Hiltunen J, Haukka J, Heikkinen J, Tiihonen J, Wang S, Neumeyer JL. Iodine-123-laheled N-(2-fluoroethyl)-2β-carbomethoxy-3β-(4-iodophenyl)nortropane for dopamine transporter imaging in the living human brain. Eur J Nucl Med 1995; 22: 682-686.
18. Abi-Dargham A, Gandelsman MS, DeErausquin GA, Zea-Ponce Y, Zoghbi SS, Baldwin RM, Laruelle M, Charney DS, Hoffer PB, Neumeyer JL, Innis RB. SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of β-CIT. J Nucl Med 1996; 37: 1129-1133.
19. Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ, Macgregor RR, Hitzemann R, Logan J, Bendriem B, Gatley SJ. Mapping cocaine binding sites in human and baboon brain in vivo. Synapse 1989; 4: 371-377.
20. Meegalla SK, Plössl K, Kung M-P, Chumpradit S, Stevenson DA, Frederick D, Kung HF. Tc-99m labeled tropanes as dopamine transporter imaging agents. Bioconj Chem 1996; 7: 421-429.
21. Meegalla SK, Plössl K, Kung M-P, Chumpradit S, Stevenson DA, Kushner SA, McElgin WT, Mozley PD, Kung HF. Synthesis and characterization of Tc-99m labeled tropanes as dopamine transporter imaging agents. J Med Chem 1997; 40: 9-17.
22. 123I]p-MPPI in nonhuman primates. Synapse 1996; 24: 273-281.
23. Kung HF, Kim H-J, Kung M-P, Meegalla SK, Plössl K, Lee H-K. Imaging of dopamine transporters in humans with technetium-99m TRODAT-1. Eur J Nucl Med 1996; 23: 1527-1530.
24. Clarke RL, Heckeler ML, Gambino AJ, Daum SJ, Harding HR, Pierson AK, Teiger DG, Pearl J, Shargel LD, Goehl TJ. (Exo,exo)-2-aryltropane3-carboxylic esters, hypoglycemic agents with accompanying analgesic activity. J Med Chem 1978; 21: 1243-1253.
25. Clarke RL, Bambino AJ, Pierson AK, Daum SJ. (2-Exo-3-endo)-2-aryltropane-3-carboxylic esters, a new class of narcotic antagonists. J Med Chem 1978; 21: 1235-1242.
26. 3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury. Brain Res 1984; 302: 9-18.
27. Munson PJ, Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand binding system. Anal Biochem 1980; 107: 220-239.
28. Essman WD, McGonigle P, Lucki I. Anatomical differentiation within the nucleus accumbens of the locomotor stimulatory actions of selective dopamine agonists and d-amphetamine. Psychopharmacology 1993; 112: 233-241.
29. Rivest R, Falardeau P, DiPaolo T. Brain dopamine transporter: gender differences and effect of chronic haloperidol. Brain Res 1995; 692: 269-272.
30. Lever SZ, Baidoo KE. Mahmood A, Matsumura K, Scheffel UA, Wagner HN Jr. Novel technetium ligands with affinity for the muscarinic cholinergic receptor. Nucl Med Biol 1994; 21: 157-164.
31. 99m/99Tc]-DADT-benzovesamicol: a potential marker for cholinergic neurons. Nucl Med Biol 1994; 21: 197-203.
32. Chi DY, O'Neil JP, Andernson CJ, Welch MJ, Katzenellenbogen JA. Homodimeric and heterodimeric bis(aminothiol) oxometal complexes with rhenium(V) and technetium(V). Control of heterodimeric complex formation and an approach to metal complexes that mimic steroid hormones. J Med Chem 1994; 37: 928-937.
33. DiZio JP, Anderson CJ, Davison A, Ehrhardt GJ, Carlson KE, Welch MJ, Katzenellenbogen JA. Technetium- and rhenium-labeled progestins: synthesis, receptor binding and in vivo distribution of an 11-β-substituted progestin labeled with technetium-99 and rhenium-186. J Nucl Med 1992; 33: 558-569.
34. O'Neil JP, Wilson SR, Katzenellenbogen JA. Preparation and structural characterization of monoamine-monoamide bis(thiol) oxo complexes of technetium(V) and rhenium(V). Inorg Chem 1994; 33: 319-323.
35. Madras BK, Jones AG, Mahmood A, Zimmerman RE, Garada B, Holman BL, Davison A, Blundell P, Meltzer PC. Technepine: a high affinity technetium-99m probe to label the dopamine transporter in brain by SPECT imaging. Synapse 1996; 22: 239-246.
36. 3H]-GBR 12935. J Neural Transm 1992; 87: 1-14.
37. 125I]RTI-55. Synapse 1992; 12: 99-111.
38. Seibyl JP, Laruelle MA, Van Dyck CH, Wallace E, Baldwin RM, Zoghbi SS, Zea-Ponce Y, Neumeyer JL, Charney DS, Hoffer PB, Innis RB. Reproducibility of iodine-123-β-CIT SPECt brain measurement of dopamine transporters. J Nucl Med 1996; 37: 222-228.
39. Meegalla SK, Plössl K, Kung M-P, Stevenson DA, Liable-Sands LM, Rheingold AL, Kung HF. First example of a Tc-99m complex as a dopamine transporter imaging agent. J Am Chem Soc 1994; 117: 11037-11038.
40. 3H]spiperone binding: evidence for accumulation in corpus striatum by agonist-mediated receptor internalization. J Cereb Blood Flow Metab 1988; 8: 291-303.
41. 3H]lysergic acid diethylamide binding in mouse cortex and hippocampus in vivo and in vitro revealed by radioautography and rapid filtration studies. J Pharmacol Exp Ther 1984; 229: 865-871.
42. Kuczenski R, Segal DS, Aizenstein ML. Amphetamine, cocaine and fencafamine: relationship between locomotor and stereotype response profiles and caudate and accumbens dopamine dynamics. J Neurosci 1991; 11: 2703-2712.